诱导多能干细胞
癌变
生物
癌症
表观遗传学
癌症治疗
精密医学
癌症治疗
癌症干细胞
癌症研究
生物信息学
生物技术
计算生物学
胚胎干细胞
遗传学
基因
作者
Matin Chehelgerdi,Fereshteh Behdarvand Dehkordi,Mohammad Chehelgerdi,Hamidreza Kabiri,Hosein Salehian-Dehkordi,Mohammad Ali Abdolvand,Sharareh Salmanizadeh,Mohsen Rashidi,Anoosha Niazmand,Saba Ahmadi,Sara Feizbakhshan,Saber Kabiri,Nasimeh Vatandoost,Tayebeh Ranjbarnejad
标识
DOI:10.1186/s12943-023-01873-0
摘要
Abstract The advent of iPSCs has brought about a significant transformation in stem cell research, opening up promising avenues for advancing cancer treatment. The formation of cancer is a multifaceted process influenced by genetic, epigenetic, and environmental factors. iPSCs offer a distinctive platform for investigating the origin of cancer, paving the way for novel approaches to cancer treatment, drug testing, and tailored medical interventions. This review article will provide an overview of the science behind iPSCs, the current limitations and challenges in iPSC-based cancer therapy, the ethical and social implications, and the comparative analysis with other stem cell types for cancer treatment. The article will also discuss the applications of iPSCs in tumorigenesis, the future of iPSCs in tumorigenesis research, and highlight successful case studies utilizing iPSCs in tumorigenesis research. The conclusion will summarize the advancements made in iPSC-based tumorigenesis research and the importance of continued investment in iPSC research to unlock the full potential of these cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI